TNB
BLRX

Thomasville National Bank’s BioLineRX BLRX Stock Holding History

Thomasville National Bank’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250
Closed -$13K – 207
2022
Q2 		$13K Hold
250
– – ﹤0.01% 212
2022
Q1 		$17K Hold
250
– – ﹤0.01% 222
2021
Q4 		$20K Hold
250
– – ﹤0.01% 223
2021
Q3 		$28K Hold
250
– – ﹤0.01% 215
2021
Q2 		$28K Buy
+250
New +$29.4K ﹤0.01% 218
2021
Q1 		– Sell
-508
Closed -$51K – 186
2020
Q4 		$51K Buy
508
+195
+62% +$17K 0.01% 201
2020
Q3 		$21K Buy
+313
New +$23.7K ﹤0.01% 191

Other funds holding BLRX

ACM
Altium Capital Management New York $42M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Thomasville National Bank's BLRX Position: Q3 2022 in Review

Thomasville National Bank sold out of BioLineRX (BLRX) in Q3 2022, closing a stake of 250 shares — an estimated $13K sold.

Thomasville National Bank first reported a position in BLRX in Q3 2020 and held it in 7 quarters. The position peaked at $51K in Q4 2020. 28 funds tracked by Wall St. Rank hold BLRX as of Q3 2022.

  • Thomasville National Bank reported no remaining BioLineRX position as of Q3 2022 after selling out during the quarter.
  • Thomasville National Bank sold 250 BioLineRX shares in Q3 2022, an estimated $13K.
  • Thomasville National Bank first reported a position in BioLineRX in Q3 2020 and held it in 7 quarters.
  • Thomasville National Bank's BioLineRX position peaked at $51K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held BioLineRX as of Q3 2022.

Based on Thomasville National Bank's 13F filing for Q3 2022, filed 3 Oct 2022.